| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Foramen Ovale, Patent | 13 | 2021 | 214 | 1.690 |
Why?
|
| Stroke | 29 | 2024 | 9962 | 0.790 |
Why?
|
| Cerebral Infarction | 25 | 2013 | 982 | 0.760 |
Why?
|
| Ischemic Attack, Transient | 13 | 2021 | 901 | 0.760 |
Why?
|
| Cerebrospinal Fluid Rhinorrhea | 2 | 2013 | 87 | 0.680 |
Why?
|
| Heart Septal Defects, Atrial | 7 | 2003 | 461 | 0.650 |
Why?
|
| Cerebrovascular Disorders | 24 | 2012 | 1501 | 0.550 |
Why?
|
| Gerstmann Syndrome | 1 | 2016 | 4 | 0.550 |
Why?
|
| Infarction, Middle Cerebral Artery | 3 | 2016 | 485 | 0.490 |
Why?
|
| Middle Cerebral Artery | 2 | 2016 | 276 | 0.490 |
Why?
|
| Blood Cells | 1 | 2016 | 305 | 0.460 |
Why?
|
| Embolism, Paradoxical | 4 | 2021 | 55 | 0.450 |
Why?
|
| Brain Ischemia | 17 | 2008 | 3127 | 0.440 |
Why?
|
| Ultrasonography, Doppler, Transcranial | 3 | 2003 | 281 | 0.420 |
Why?
|
| Blood Patch, Epidural | 1 | 2013 | 56 | 0.420 |
Why?
|
| Intracranial Hypotension | 1 | 2013 | 40 | 0.420 |
Why?
|
| Carotid Artery, Internal, Dissection | 1 | 2012 | 42 | 0.400 |
Why?
|
| Cranial Nerve Diseases | 1 | 2012 | 112 | 0.390 |
Why?
|
| Thrombophilia | 4 | 2021 | 306 | 0.380 |
Why?
|
| Nifedipine | 1 | 2011 | 221 | 0.370 |
Why?
|
| Paralysis | 1 | 2012 | 251 | 0.360 |
Why?
|
| Magnetic Resonance Spectroscopy | 29 | 1987 | 3765 | 0.330 |
Why?
|
| Vasospasm, Intracranial | 3 | 2007 | 215 | 0.330 |
Why?
|
| Carotid Artery, Internal | 4 | 2013 | 438 | 0.310 |
Why?
|
| Embolism | 3 | 2020 | 408 | 0.310 |
Why?
|
| Subarachnoid Hemorrhage | 9 | 2007 | 1032 | 0.310 |
Why?
|
| Anemia, Sickle Cell | 1 | 2016 | 1056 | 0.290 |
Why?
|
| Vasodilator Agents | 2 | 2011 | 978 | 0.290 |
Why?
|
| Pneumocephalus | 1 | 2006 | 47 | 0.270 |
Why?
|
| Cerebrovascular Circulation | 15 | 2021 | 2733 | 0.260 |
Why?
|
| Migraine Disorders | 3 | 2020 | 1693 | 0.260 |
Why?
|
| Iatrogenic Disease | 1 | 2008 | 538 | 0.240 |
Why?
|
| Brain | 41 | 2020 | 26951 | 0.240 |
Why?
|
| Cerebral Angiography | 13 | 2010 | 1274 | 0.210 |
Why?
|
| Carbon Dioxide | 3 | 2021 | 1146 | 0.210 |
Why?
|
| Brain Edema | 5 | 2011 | 603 | 0.210 |
Why?
|
| Eye Diseases | 1 | 2008 | 651 | 0.210 |
Why?
|
| Brain Diseases | 6 | 2008 | 1540 | 0.210 |
Why?
|
| Arterial Occlusive Diseases | 5 | 2012 | 752 | 0.200 |
Why?
|
| Brain Stem Infarctions | 2 | 2001 | 31 | 0.190 |
Why?
|
| Nasal Polyps | 1 | 2006 | 395 | 0.190 |
Why?
|
| Tomography, X-Ray Computed | 40 | 2016 | 20509 | 0.180 |
Why?
|
| Magnetic Resonance Imaging | 30 | 2021 | 36290 | 0.170 |
Why?
|
| Intracranial Embolism and Thrombosis | 7 | 1998 | 144 | 0.160 |
Why?
|
| Male | 91 | 2024 | 359744 | 0.150 |
Why?
|
| Endocarditis | 1 | 2002 | 351 | 0.150 |
Why?
|
| Sinus Thrombosis, Intracranial | 4 | 1998 | 110 | 0.150 |
Why?
|
| Intracranial Aneurysm | 6 | 2010 | 1276 | 0.140 |
Why?
|
| Sulfonamides | 1 | 2007 | 1977 | 0.140 |
Why?
|
| Antihypertensive Agents | 1 | 2007 | 2061 | 0.140 |
Why?
|
| Echocardiography | 5 | 2020 | 4981 | 0.140 |
Why?
|
| Middle Aged | 70 | 2024 | 220352 | 0.140 |
Why?
|
| Dominance, Cerebral | 2 | 1998 | 622 | 0.140 |
Why?
|
| Proteomics | 4 | 2017 | 3817 | 0.140 |
Why?
|
| Vertebral Artery | 2 | 1996 | 185 | 0.140 |
Why?
|
| Humans | 140 | 2024 | 760621 | 0.140 |
Why?
|
| Encephalocele | 2 | 1997 | 135 | 0.140 |
Why?
|
| Jugular Veins | 2 | 2010 | 211 | 0.130 |
Why?
|
| Septal Occluder Device | 4 | 2020 | 126 | 0.130 |
Why?
|
| Tomography | 8 | 1984 | 411 | 0.130 |
Why?
|
| Neurosurgical Procedures | 1 | 2006 | 2056 | 0.130 |
Why?
|
| Natriuretic Peptide, Brain | 1 | 2024 | 1717 | 0.130 |
Why?
|
| Heart Arrest | 2 | 2017 | 1506 | 0.120 |
Why?
|
| Speech Disorders | 2 | 2016 | 180 | 0.120 |
Why?
|
| Hematologic Tests | 1 | 2016 | 238 | 0.120 |
Why?
|
| Oxygen Consumption | 1 | 2021 | 1843 | 0.120 |
Why?
|
| Syndrome | 6 | 2008 | 3280 | 0.120 |
Why?
|
| Hypothermia, Induced | 2 | 2017 | 758 | 0.120 |
Why?
|
| Fibrinolytic Agents | 4 | 2013 | 2167 | 0.120 |
Why?
|
| Vasa Vasorum | 1 | 2013 | 25 | 0.110 |
Why?
|
| Coronary Circulation | 1 | 2020 | 1577 | 0.110 |
Why?
|
| Female | 91 | 2024 | 391270 | 0.110 |
Why?
|
| Adult | 64 | 2021 | 219994 | 0.110 |
Why?
|
| Carotid Stenosis | 3 | 2013 | 878 | 0.110 |
Why?
|
| Recurrence | 6 | 2021 | 8482 | 0.110 |
Why?
|
| Central Nervous System Diseases | 2 | 2010 | 521 | 0.110 |
Why?
|
| Cerebral Hemorrhage | 10 | 2010 | 2660 | 0.110 |
Why?
|
| Mass Spectrometry | 3 | 2021 | 2192 | 0.100 |
Why?
|
| Craniotomy | 1 | 1997 | 741 | 0.100 |
Why?
|
| Tomography, Emission-Computed | 5 | 1998 | 1121 | 0.100 |
Why?
|
| Biomarkers, Pharmacological | 1 | 2013 | 162 | 0.100 |
Why?
|
| Hemorrhagic Disorders | 1 | 2012 | 35 | 0.100 |
Why?
|
| Hoarseness | 1 | 2012 | 62 | 0.100 |
Why?
|
| Cardiomyopathies | 1 | 2024 | 1952 | 0.100 |
Why?
|
| Decompression, Surgical | 1 | 1997 | 604 | 0.100 |
Why?
|
| Occipital Lobe | 1 | 2013 | 373 | 0.100 |
Why?
|
| Acute Disease | 12 | 2002 | 7269 | 0.100 |
Why?
|
| Diagnosis, Differential | 9 | 2016 | 12965 | 0.090 |
Why?
|
| Factor XIII Deficiency | 1 | 2010 | 16 | 0.090 |
Why?
|
| Motion Perception | 1 | 2014 | 372 | 0.090 |
Why?
|
| Treatment Outcome | 17 | 2021 | 65017 | 0.090 |
Why?
|
| Motion | 1 | 2014 | 779 | 0.090 |
Why?
|
| Neck Pain | 1 | 2012 | 186 | 0.090 |
Why?
|
| ROC Curve | 4 | 2017 | 3568 | 0.090 |
Why?
|
| Visual Pathways | 2 | 2013 | 534 | 0.090 |
Why?
|
| Task Performance and Analysis | 1 | 2014 | 759 | 0.090 |
Why?
|
| Thromboembolism | 2 | 2016 | 1017 | 0.090 |
Why?
|
| Brain Concussion | 2 | 2021 | 1394 | 0.090 |
Why?
|
| Brain Infarction | 1 | 2012 | 292 | 0.090 |
Why?
|
| Aged | 54 | 2024 | 169152 | 0.090 |
Why?
|
| Apolipoproteins | 1 | 2012 | 320 | 0.090 |
Why?
|
| Glycoproteins | 1 | 2017 | 2208 | 0.080 |
Why?
|
| Embolization, Therapeutic | 2 | 2010 | 1413 | 0.080 |
Why?
|
| Siderosis | 1 | 2010 | 103 | 0.080 |
Why?
|
| Phenylephrine | 2 | 2001 | 293 | 0.080 |
Why?
|
| Aspirin | 1 | 2020 | 3364 | 0.080 |
Why?
|
| Headache | 1 | 2016 | 1249 | 0.080 |
Why?
|
| Thrombosis | 1 | 2002 | 3052 | 0.070 |
Why?
|
| Elastomers | 1 | 2008 | 69 | 0.070 |
Why?
|
| Intracranial Embolism | 2 | 2013 | 192 | 0.070 |
Why?
|
| Platelet Aggregation Inhibitors | 1 | 2020 | 3201 | 0.070 |
Why?
|
| Influenza A Virus, H1N1 Subtype | 1 | 2011 | 448 | 0.070 |
Why?
|
| Magnetic Resonance Angiography | 8 | 2010 | 1431 | 0.070 |
Why?
|
| Thrombolytic Therapy | 3 | 2008 | 2108 | 0.070 |
Why?
|
| Anticoagulants | 5 | 2021 | 4897 | 0.070 |
Why?
|
| Postoperative Complications | 5 | 2006 | 15697 | 0.070 |
Why?
|
| Cervical Vertebrae | 2 | 2013 | 978 | 0.070 |
Why?
|
| Central Nervous System Vascular Malformations | 1 | 2008 | 140 | 0.070 |
Why?
|
| Visual Perception | 2 | 2013 | 1374 | 0.070 |
Why?
|
| Nervous System Diseases | 1 | 2017 | 1647 | 0.070 |
Why?
|
| Cerebral Veins | 2 | 1999 | 157 | 0.070 |
Why?
|
| Endarterectomy | 3 | 1997 | 195 | 0.070 |
Why?
|
| Blood Proteins | 1 | 2012 | 1173 | 0.070 |
Why?
|
| Cerebral Revascularization | 1 | 2009 | 249 | 0.070 |
Why?
|
| Blood Pressure | 5 | 2008 | 8525 | 0.070 |
Why?
|
| Iliac Vein | 2 | 2009 | 70 | 0.070 |
Why?
|
| Echocardiography, Transesophageal | 2 | 2003 | 1108 | 0.070 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2012 | 1189 | 0.070 |
Why?
|
| Deglutition Disorders | 1 | 2012 | 626 | 0.070 |
Why?
|
| Vascular Diseases | 2 | 2009 | 1182 | 0.060 |
Why?
|
| Intracranial Arteriosclerosis | 3 | 2005 | 137 | 0.060 |
Why?
|
| Parkinsonian Disorders | 1 | 2008 | 284 | 0.060 |
Why?
|
| Prospective Studies | 9 | 2024 | 54303 | 0.060 |
Why?
|
| Neuronal Plasticity | 1 | 2013 | 1430 | 0.060 |
Why?
|
| Aphasia | 2 | 2003 | 192 | 0.060 |
Why?
|
| Risk Factors | 12 | 2024 | 74359 | 0.060 |
Why?
|
| Vision Disorders | 1 | 2012 | 1084 | 0.060 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 1989 | 2502 | 0.060 |
Why?
|
| Basilar Artery | 3 | 2005 | 205 | 0.060 |
Why?
|
| Angiography | 2 | 2013 | 1605 | 0.060 |
Why?
|
| Adenocarcinoma | 1 | 2002 | 6315 | 0.060 |
Why?
|
| Proteome | 2 | 2012 | 1855 | 0.060 |
Why?
|
| Sensitivity and Specificity | 7 | 2003 | 14660 | 0.060 |
Why?
|
| Amaurosis Fugax | 1 | 2003 | 7 | 0.060 |
Why?
|
| Angioplasty, Balloon | 1 | 2008 | 597 | 0.060 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2019 | 3334 | 0.060 |
Why?
|
| Pilot Projects | 4 | 2007 | 8555 | 0.050 |
Why?
|
| Secondary Prevention | 3 | 2020 | 1548 | 0.050 |
Why?
|
| Bartonella Infections | 1 | 2003 | 21 | 0.050 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 3 | 2020 | 2782 | 0.050 |
Why?
|
| Hypertension | 4 | 2001 | 8594 | 0.050 |
Why?
|
| Heart Septal Defects | 1 | 2003 | 191 | 0.050 |
Why?
|
| Pregnancy Complications | 1 | 2016 | 2942 | 0.050 |
Why?
|
| Oxygen Inhalation Therapy | 1 | 2005 | 404 | 0.050 |
Why?
|
| Hemodynamics | 2 | 2010 | 4174 | 0.050 |
Why?
|
| Brain Injury, Chronic | 1 | 2021 | 68 | 0.050 |
Why?
|
| Venous Thrombosis | 1 | 2010 | 1299 | 0.050 |
Why?
|
| Predictive Value of Tests | 9 | 2005 | 15289 | 0.050 |
Why?
|
| Hemiplegia | 2 | 1998 | 136 | 0.050 |
Why?
|
| Aged, 80 and over | 17 | 2013 | 58995 | 0.050 |
Why?
|
| Frontal Lobe | 2 | 2006 | 1420 | 0.050 |
Why?
|
| Intracranial Thrombosis | 1 | 2001 | 109 | 0.040 |
Why?
|
| Prognosis | 6 | 2024 | 29658 | 0.040 |
Why?
|
| Sagittal Sinus Thrombosis | 1 | 1999 | 11 | 0.040 |
Why?
|
| Young Adult | 6 | 2021 | 58741 | 0.040 |
Why?
|
| Neurologic Examination | 3 | 2017 | 916 | 0.040 |
Why?
|
| Iliac Artery | 1 | 2001 | 344 | 0.040 |
Why?
|
| Influenza, Human | 1 | 2011 | 1528 | 0.040 |
Why?
|
| Liver Cirrhosis, Alcoholic | 1 | 1999 | 64 | 0.040 |
Why?
|
| Oxidative Stress | 1 | 2010 | 3106 | 0.040 |
Why?
|
| Pulmonary Gas Exchange | 1 | 2021 | 378 | 0.040 |
Why?
|
| Phlebography | 3 | 2009 | 325 | 0.040 |
Why?
|
| Disseminated Intravascular Coagulation | 1 | 1980 | 187 | 0.040 |
Why?
|
| Carotid Artery Diseases | 3 | 1998 | 883 | 0.040 |
Why?
|
| Tissue Plasminogen Activator | 1 | 2005 | 1190 | 0.040 |
Why?
|
| Astrocytoma | 3 | 1983 | 775 | 0.040 |
Why?
|
| Glasgow Coma Scale | 1 | 2021 | 579 | 0.040 |
Why?
|
| Protein C Deficiency | 1 | 1998 | 25 | 0.040 |
Why?
|
| Follow-Up Studies | 6 | 2024 | 39261 | 0.040 |
Why?
|
| Encephalitis | 1 | 2003 | 437 | 0.040 |
Why?
|
| Cerebral Arteries | 2 | 1998 | 493 | 0.040 |
Why?
|
| Drug Administration Schedule | 1 | 2007 | 4899 | 0.040 |
Why?
|
| Retrospective Studies | 13 | 2020 | 80372 | 0.040 |
Why?
|
| Endothelium, Vascular | 1 | 2010 | 4433 | 0.040 |
Why?
|
| Post-Concussion Syndrome | 1 | 2021 | 238 | 0.040 |
Why?
|
| Mutism | 1 | 1998 | 26 | 0.040 |
Why?
|
| Time Factors | 11 | 2020 | 40165 | 0.040 |
Why?
|
| Cohort Studies | 5 | 2021 | 41335 | 0.040 |
Why?
|
| Leukodystrophy, Metachromatic | 1 | 1978 | 44 | 0.040 |
Why?
|
| Homocysteine | 1 | 2021 | 640 | 0.040 |
Why?
|
| Heart Atria | 1 | 2024 | 1346 | 0.040 |
Why?
|
| Endothelial Cells | 1 | 2010 | 3539 | 0.040 |
Why?
|
| Constriction, Pathologic | 1 | 2001 | 1098 | 0.040 |
Why?
|
| Feasibility Studies | 2 | 2007 | 5201 | 0.040 |
Why?
|
| Thrombophlebitis | 1 | 1998 | 288 | 0.040 |
Why?
|
| Photic Stimulation | 2 | 2014 | 1967 | 0.040 |
Why?
|
| Ceruloplasmin | 1 | 2017 | 56 | 0.040 |
Why?
|
| Mitral Valve Prolapse | 1 | 1999 | 215 | 0.040 |
Why?
|
| Carotid Artery Injuries | 1 | 1998 | 96 | 0.040 |
Why?
|
| Status Epilepticus | 1 | 2003 | 456 | 0.040 |
Why?
|
| Algorithms | 2 | 2012 | 13981 | 0.030 |
Why?
|
| Eclampsia | 1 | 1997 | 56 | 0.030 |
Why?
|
| Survival Rate | 2 | 2024 | 12808 | 0.030 |
Why?
|
| Hyperglycemia | 1 | 2005 | 1380 | 0.030 |
Why?
|
| Haptoglobins | 1 | 2017 | 167 | 0.030 |
Why?
|
| Hydrocephalus, Normal Pressure | 1 | 1997 | 99 | 0.030 |
Why?
|
| Confusion | 1 | 1998 | 279 | 0.030 |
Why?
|
| Functional Laterality | 2 | 1998 | 2253 | 0.030 |
Why?
|
| Echo-Planar Imaging | 2 | 1999 | 657 | 0.030 |
Why?
|
| Motor Cortex | 1 | 2003 | 995 | 0.030 |
Why?
|
| Cardiac Surgical Procedures | 2 | 2002 | 3620 | 0.030 |
Why?
|
| Optic Flow | 1 | 2014 | 13 | 0.030 |
Why?
|
| Gene Expression Regulation | 1 | 2012 | 11903 | 0.030 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2007 | 10827 | 0.030 |
Why?
|
| Awareness | 1 | 1998 | 646 | 0.030 |
Why?
|
| Vasoconstrictor Agents | 1 | 1997 | 651 | 0.030 |
Why?
|
| Substantia Nigra | 1 | 1975 | 350 | 0.030 |
Why?
|
| Pelvis | 1 | 1998 | 743 | 0.030 |
Why?
|
| Fever | 1 | 2001 | 1617 | 0.030 |
Why?
|
| Psychophysics | 1 | 2013 | 289 | 0.030 |
Why?
|
| Mandible | 1 | 1998 | 750 | 0.030 |
Why?
|
| Hand | 1 | 1998 | 903 | 0.030 |
Why?
|
| Tritium | 2 | 1983 | 707 | 0.030 |
Why?
|
| Hematoma | 3 | 2005 | 769 | 0.030 |
Why?
|
| China | 1 | 2019 | 2339 | 0.030 |
Why?
|
| Regional Blood Flow | 3 | 2005 | 1490 | 0.030 |
Why?
|
| Osteotomy | 1 | 1998 | 836 | 0.030 |
Why?
|
| Gerbillinae | 2 | 1983 | 87 | 0.030 |
Why?
|
| Retina | 2 | 2013 | 2635 | 0.030 |
Why?
|
| Pons | 2 | 1984 | 239 | 0.020 |
Why?
|
| Protons | 5 | 1983 | 1114 | 0.020 |
Why?
|
| Thalamus | 1 | 1998 | 1041 | 0.020 |
Why?
|
| Cranial Sinuses | 2 | 1984 | 68 | 0.020 |
Why?
|
| Disease Progression | 4 | 2002 | 13502 | 0.020 |
Why?
|
| Peptide Fragments | 1 | 2024 | 5125 | 0.020 |
Why?
|
| Demyelinating Diseases | 2 | 1984 | 351 | 0.020 |
Why?
|
| Pregnancy | 4 | 2016 | 29749 | 0.020 |
Why?
|
| Limit of Detection | 1 | 2012 | 280 | 0.020 |
Why?
|
| Endarterectomy, Carotid | 1 | 1996 | 564 | 0.020 |
Why?
|
| Thalamic Diseases | 1 | 2010 | 15 | 0.020 |
Why?
|
| Body Water | 1 | 1992 | 341 | 0.020 |
Why?
|
| Activities of Daily Living | 2 | 1997 | 2417 | 0.020 |
Why?
|
| Carbon Radioisotopes | 2 | 1989 | 557 | 0.020 |
Why?
|
| Mathematics | 2 | 1989 | 707 | 0.020 |
Why?
|
| Drug Therapy, Combination | 1 | 2020 | 6498 | 0.020 |
Why?
|
| Contrast Media | 1 | 2003 | 5305 | 0.020 |
Why?
|
| Ischemia | 2 | 2012 | 1893 | 0.020 |
Why?
|
| Diffusion | 3 | 1998 | 813 | 0.020 |
Why?
|
| Free Radical Scavengers | 1 | 2010 | 211 | 0.020 |
Why?
|
| Disability Evaluation | 1 | 1997 | 1826 | 0.020 |
Why?
|
| Intracranial Arteriovenous Malformations | 3 | 1984 | 367 | 0.020 |
Why?
|
| Dementia | 3 | 1997 | 2649 | 0.020 |
Why?
|
| Blood Coagulation Tests | 1 | 2010 | 270 | 0.020 |
Why?
|
| Signal Transduction | 1 | 2012 | 23376 | 0.020 |
Why?
|
| Corpus Striatum | 1 | 1975 | 1233 | 0.020 |
Why?
|
| Hospitals, General | 1 | 2013 | 795 | 0.020 |
Why?
|
| Boston | 2 | 2013 | 9280 | 0.020 |
Why?
|
| Echocardiography, Doppler, Color | 1 | 2010 | 354 | 0.020 |
Why?
|
| Chromatography, Liquid | 1 | 2012 | 987 | 0.020 |
Why?
|
| Brain Neoplasms | 6 | 1984 | 8986 | 0.020 |
Why?
|
| Blood Volume | 2 | 2001 | 550 | 0.020 |
Why?
|
| International Normalized Ratio | 1 | 2010 | 386 | 0.020 |
Why?
|
| Motor Activity | 1 | 1998 | 2687 | 0.020 |
Why?
|
| Multiple Sclerosis | 1 | 1983 | 3204 | 0.020 |
Why?
|
| Attention | 1 | 1998 | 2387 | 0.020 |
Why?
|
| Cerebral Ventricles | 1 | 1990 | 542 | 0.020 |
Why?
|
| Diagnostic Imaging | 1 | 2001 | 3527 | 0.020 |
Why?
|
| Plasma | 1 | 2010 | 584 | 0.020 |
Why?
|
| Wallerian Degeneration | 1 | 1987 | 68 | 0.020 |
Why?
|
| Angiography, Digital Subtraction | 1 | 2008 | 334 | 0.020 |
Why?
|
| Carotid Arteries | 1 | 1991 | 951 | 0.020 |
Why?
|
| Electroencephalography | 3 | 1998 | 6189 | 0.020 |
Why?
|
| Cause of Death | 1 | 1997 | 3725 | 0.020 |
Why?
|
| Chronic Disease | 1 | 2021 | 9287 | 0.020 |
Why?
|
| Perfusion | 2 | 2003 | 1376 | 0.020 |
Why?
|
| Tinnitus | 1 | 2008 | 194 | 0.020 |
Why?
|
| Magnetics | 3 | 1984 | 600 | 0.020 |
Why?
|
| Prostheses and Implants | 2 | 2002 | 1273 | 0.020 |
Why?
|
| Blood Physiological Phenomena | 1 | 1985 | 53 | 0.020 |
Why?
|
| Radionuclide Imaging | 2 | 1980 | 1975 | 0.020 |
Why?
|
| Blood Flow Velocity | 2 | 2001 | 1377 | 0.020 |
Why?
|
| Electrocardiography | 1 | 1998 | 6414 | 0.020 |
Why?
|
| Hospitals | 1 | 2019 | 3928 | 0.020 |
Why?
|
| Pituitary Neoplasms | 2 | 1984 | 1313 | 0.020 |
Why?
|
| Evaluation Studies as Topic | 3 | 1988 | 1628 | 0.020 |
Why?
|
| Catheterization | 1 | 2010 | 1432 | 0.020 |
Why?
|
| Pressure | 1 | 2008 | 1156 | 0.010 |
Why?
|
| Models, Cardiovascular | 1 | 1989 | 978 | 0.010 |
Why?
|
| Chi-Square Distribution | 1 | 2010 | 3465 | 0.010 |
Why?
|
| Sex Distribution | 1 | 2009 | 2295 | 0.010 |
Why?
|
| Risk Assessment | 4 | 2010 | 24123 | 0.010 |
Why?
|
| Nervous System Neoplasms | 1 | 1983 | 91 | 0.010 |
Why?
|
| Hyperoxia | 1 | 2005 | 250 | 0.010 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2013 | 6544 | 0.010 |
Why?
|
| Child | 5 | 2002 | 79806 | 0.010 |
Why?
|
| Phospholipids | 1 | 1986 | 789 | 0.010 |
Why?
|
| Brain Mapping | 2 | 2013 | 6568 | 0.010 |
Why?
|
| Dental Materials | 1 | 1983 | 113 | 0.010 |
Why?
|
| Injections, Intravenous | 1 | 2005 | 1385 | 0.010 |
Why?
|
| Syringomyelia | 1 | 1983 | 67 | 0.010 |
Why?
|
| Arteriosclerosis | 1 | 1987 | 1064 | 0.010 |
Why?
|
| Reference Values | 1 | 1989 | 4925 | 0.010 |
Why?
|
| Giant Cell Tumors | 1 | 1982 | 90 | 0.010 |
Why?
|
| Logistic Models | 2 | 2010 | 13314 | 0.010 |
Why?
|
| Kinetics | 1 | 1989 | 6377 | 0.010 |
Why?
|
| Inflammation Mediators | 1 | 2010 | 1881 | 0.010 |
Why?
|
| Severity of Illness Index | 2 | 2013 | 15840 | 0.010 |
Why?
|
| Nitric Oxide | 1 | 2010 | 2141 | 0.010 |
Why?
|
| Recovery of Function | 2 | 2003 | 2985 | 0.010 |
Why?
|
| Prothrombin | 1 | 2002 | 191 | 0.010 |
Why?
|
| Agnosia | 1 | 1982 | 66 | 0.010 |
Why?
|
| Factor V | 1 | 2002 | 168 | 0.010 |
Why?
|
| Models, Neurological | 1 | 1989 | 1758 | 0.010 |
Why?
|
| Patient Selection | 1 | 2013 | 4283 | 0.010 |
Why?
|
| Cardiac Tamponade | 1 | 2002 | 174 | 0.010 |
Why?
|
| Arnold-Chiari Malformation | 1 | 1983 | 158 | 0.010 |
Why?
|
| Coma | 1 | 1984 | 487 | 0.010 |
Why?
|
| Cats | 1 | 1982 | 976 | 0.010 |
Why?
|
| Foreign-Body Migration | 1 | 2002 | 218 | 0.010 |
Why?
|
| Barbiturates | 1 | 1981 | 113 | 0.010 |
Why?
|
| Amino Acid Sequence | 1 | 2012 | 13451 | 0.010 |
Why?
|
| Radiographic Image Enhancement | 2 | 2001 | 875 | 0.010 |
Why?
|
| Adolescent | 7 | 1998 | 87810 | 0.010 |
Why?
|
| Age Factors | 2 | 2016 | 18416 | 0.010 |
Why?
|
| Nerve Tissue Proteins | 1 | 2012 | 4407 | 0.010 |
Why?
|
| Hyperbaric Oxygenation | 1 | 1981 | 166 | 0.010 |
Why?
|
| Equipment Design | 1 | 2008 | 3520 | 0.010 |
Why?
|
| Cerebral Arterial Diseases | 1 | 1999 | 82 | 0.010 |
Why?
|
| Heart | 1 | 2012 | 4393 | 0.010 |
Why?
|
| Temporal Arteries | 1 | 1981 | 148 | 0.010 |
Why?
|
| Molecular Sequence Data | 1 | 2012 | 17624 | 0.010 |
Why?
|
| False Negative Reactions | 2 | 1995 | 573 | 0.010 |
Why?
|
| Case-Control Studies | 2 | 2012 | 22053 | 0.010 |
Why?
|
| Cerebellar Diseases | 2 | 1984 | 219 | 0.010 |
Why?
|
| Warfarin | 2 | 1998 | 1518 | 0.010 |
Why?
|
| Technetium | 1 | 1979 | 321 | 0.010 |
Why?
|
| Ventilators, Mechanical | 1 | 1981 | 287 | 0.010 |
Why?
|
| Metals | 1 | 1983 | 736 | 0.010 |
Why?
|
| Carotid Artery Thrombosis | 1 | 1998 | 51 | 0.010 |
Why?
|
| Prognathism | 1 | 1998 | 26 | 0.010 |
Why?
|
| Differential Threshold | 1 | 1997 | 80 | 0.010 |
Why?
|
| Single-Blind Method | 1 | 2002 | 1578 | 0.010 |
Why?
|
| Critical Care | 1 | 2010 | 2699 | 0.010 |
Why?
|
| Heparin, Low-Molecular-Weight | 1 | 1999 | 345 | 0.010 |
Why?
|
| Sensation Disorders | 1 | 1998 | 160 | 0.010 |
Why?
|
| Odds Ratio | 2 | 2000 | 9716 | 0.010 |
Why?
|
| Hematoma, Subdural | 1 | 1978 | 126 | 0.010 |
Why?
|
| Platelet Aggregation | 1 | 1981 | 805 | 0.010 |
Why?
|
| Lipoprotein(a) | 1 | 2002 | 499 | 0.010 |
Why?
|
| Multivariate Analysis | 2 | 2001 | 12159 | 0.010 |
Why?
|
| Parietal Lobe | 1 | 1982 | 850 | 0.010 |
Why?
|
| Pseudotumor Cerebri | 1 | 1978 | 108 | 0.010 |
Why?
|
| Cell Line | 1 | 2010 | 15620 | 0.010 |
Why?
|
| Creutzfeldt-Jakob Syndrome | 1 | 1997 | 91 | 0.010 |
Why?
|
| Demography | 1 | 2001 | 1650 | 0.010 |
Why?
|
| Blood Coagulation Disorders | 1 | 1999 | 349 | 0.010 |
Why?
|
| Oxygen | 2 | 2005 | 4193 | 0.010 |
Why?
|
| Ventriculoperitoneal Shunt | 1 | 1997 | 186 | 0.010 |
Why?
|
| Combined Modality Therapy | 1 | 2008 | 8552 | 0.010 |
Why?
|
| Rats | 2 | 1983 | 23711 | 0.010 |
Why?
|
| Systole | 1 | 1997 | 947 | 0.010 |
Why?
|
| Levodopa | 1 | 1975 | 217 | 0.010 |
Why?
|
| Causality | 1 | 2001 | 1242 | 0.010 |
Why?
|
| Muscle Hypotonia | 1 | 1996 | 160 | 0.010 |
Why?
|
| Myoclonus | 1 | 1975 | 107 | 0.010 |
Why?
|
| Animals | 6 | 2012 | 167963 | 0.010 |
Why?
|
| Maxilla | 1 | 1998 | 491 | 0.010 |
Why?
|
| Ultrasonography, Doppler | 1 | 1996 | 465 | 0.010 |
Why?
|
| Observer Variation | 1 | 2000 | 2601 | 0.010 |
Why?
|
| Meningioma | 2 | 1983 | 1221 | 0.010 |
Why?
|
| Phosphorus | 2 | 1986 | 333 | 0.010 |
Why?
|
| Alzheimer Disease | 3 | 1997 | 8547 | 0.010 |
Why?
|
| Biopsy | 2 | 1982 | 6771 | 0.010 |
Why?
|
| Meningeal Neoplasms | 2 | 1983 | 1249 | 0.010 |
Why?
|
| Psychotic Disorders | 1 | 1988 | 3193 | 0.010 |
Why?
|
| Adenoma | 1 | 1984 | 2148 | 0.010 |
Why?
|
| Bone Neoplasms | 2 | 1982 | 2532 | 0.010 |
Why?
|
| Clinical Trials as Topic | 1 | 2009 | 8056 | 0.010 |
Why?
|
| Child, Preschool | 4 | 1980 | 42063 | 0.010 |
Why?
|
| Physical Phenomena | 2 | 1983 | 48 | 0.010 |
Why?
|
| Vasodilation | 1 | 1997 | 962 | 0.010 |
Why?
|
| Safety | 1 | 1997 | 1148 | 0.010 |
Why?
|
| Postoperative Period | 1 | 1997 | 1818 | 0.010 |
Why?
|
| Infant, Newborn | 2 | 2007 | 26181 | 0.010 |
Why?
|
| Physics | 2 | 1983 | 90 | 0.010 |
Why?
|
| Spinal Cord | 2 | 1983 | 1817 | 0.010 |
Why?
|
| Arteries | 1 | 1997 | 1126 | 0.010 |
Why?
|
| Length of Stay | 1 | 2005 | 6479 | 0.010 |
Why?
|
| Reperfusion Injury | 1 | 1998 | 1023 | 0.010 |
Why?
|
| Risk | 1 | 2003 | 9631 | 0.010 |
Why?
|
| Anticonvulsants | 1 | 1981 | 1879 | 0.010 |
Why?
|
| Blood Glucose | 1 | 2005 | 6381 | 0.010 |
Why?
|
| Mitral Valve | 1 | 1999 | 1486 | 0.010 |
Why?
|
| Incidence | 1 | 2009 | 21392 | 0.010 |
Why?
|
| Radiography | 2 | 1997 | 6965 | 0.010 |
Why?
|
| Drug Combinations | 1 | 1996 | 2025 | 0.010 |
Why?
|
| Cerebellum | 1 | 1997 | 1496 | 0.010 |
Why?
|
| Hepatitis C | 1 | 1999 | 1579 | 0.010 |
Why?
|
| Heparin | 1 | 1996 | 1652 | 0.000 |
Why?
|
| Liver Transplantation | 1 | 1999 | 2325 | 0.000 |
Why?
|
| Coronary Disease | 1 | 1982 | 5990 | 0.000 |
Why?
|
| Dogs | 2 | 1982 | 3841 | 0.000 |
Why?
|
| Axons | 1 | 1975 | 1673 | 0.000 |
Why?
|
| Cerebral Cortex | 2 | 1998 | 5761 | 0.000 |
Why?
|
| X-Rays | 1 | 1987 | 307 | 0.000 |
Why?
|
| Heart Diseases | 1 | 1999 | 2809 | 0.000 |
Why?
|
| Autopsy | 1 | 1990 | 1007 | 0.000 |
Why?
|
| Models, Statistical | 1 | 2001 | 5075 | 0.000 |
Why?
|
| Atrophy | 2 | 1984 | 1627 | 0.000 |
Why?
|
| Vertebrobasilar Insufficiency | 1 | 1986 | 112 | 0.000 |
Why?
|
| Empyema, Subdural | 1 | 1984 | 12 | 0.000 |
Why?
|
| Spectrum Analysis | 1 | 1986 | 453 | 0.000 |
Why?
|
| Aging | 1 | 1983 | 8651 | 0.000 |
Why?
|
| Pneumoencephalography | 1 | 1983 | 22 | 0.000 |
Why?
|
| Image Interpretation, Computer-Assisted | 1 | 1996 | 3340 | 0.000 |
Why?
|
| Cerebellopontine Angle | 1 | 1983 | 53 | 0.000 |
Why?
|
| Myelography | 1 | 1983 | 72 | 0.000 |
Why?
|
| Pulse | 1 | 1983 | 218 | 0.000 |
Why?
|
| Cranial Fossa, Posterior | 1 | 1983 | 135 | 0.000 |
Why?
|
| Electron Spin Resonance Spectroscopy | 1 | 1982 | 162 | 0.000 |
Why?
|
| Oxygen Radioisotopes | 1 | 1982 | 75 | 0.000 |
Why?
|
| Hemostasis, Surgical | 1 | 1983 | 129 | 0.000 |
Why?
|
| Fluorine | 1 | 1982 | 83 | 0.000 |
Why?
|
| Prevalence | 1 | 1999 | 15687 | 0.000 |
Why?
|
| Nuclear Physics | 1 | 1982 | 75 | 0.000 |
Why?
|
| Apraxias | 1 | 1982 | 59 | 0.000 |
Why?
|
| Hematocrit | 1 | 1983 | 629 | 0.000 |
Why?
|
| Myocardial Infarction | 1 | 1982 | 11891 | 0.000 |
Why?
|
| Cognition | 1 | 1998 | 6957 | 0.000 |
Why?
|
| Radioisotopes | 1 | 1982 | 495 | 0.000 |
Why?
|
| Chordoma | 1 | 1983 | 346 | 0.000 |
Why?
|
| Orientation | 1 | 1982 | 321 | 0.000 |
Why?
|
| Discrimination Learning | 1 | 1982 | 278 | 0.000 |
Why?
|
| Vascular Resistance | 1 | 1983 | 933 | 0.000 |
Why?
|
| Aneurysm | 1 | 1983 | 337 | 0.000 |
Why?
|
| Forearm | 1 | 1982 | 429 | 0.000 |
Why?
|
| Epilepsy | 1 | 1975 | 3267 | 0.000 |
Why?
|
| Psychological Tests | 1 | 1982 | 639 | 0.000 |
Why?
|
| Neuroma, Acoustic | 1 | 1983 | 459 | 0.000 |
Why?
|
| Manganese | 1 | 1982 | 395 | 0.000 |
Why?
|
| Radius | 1 | 1982 | 440 | 0.000 |
Why?
|
| Cerebellar Neoplasms | 1 | 1983 | 587 | 0.000 |
Why?
|
| Staining and Labeling | 1 | 1982 | 1089 | 0.000 |
Why?
|
| Glioma | 2 | 1983 | 3420 | 0.000 |
Why?
|
| Hydrocephalus | 1 | 1984 | 763 | 0.000 |
Why?
|
| Myoclonic Cerebellar Dyssynergia | 1 | 1975 | 1 | 0.000 |
Why?
|
| Pattern Recognition, Visual | 1 | 1982 | 810 | 0.000 |
Why?
|
| Visual Fields | 1 | 1982 | 1054 | 0.000 |
Why?
|
| Terminology as Topic | 1 | 1982 | 1535 | 0.000 |
Why?
|
| Veins | 1 | 1979 | 765 | 0.000 |
Why?
|
| Cerebellar Ataxia | 1 | 1975 | 149 | 0.000 |
Why?
|
| Quadriplegia | 1 | 1975 | 226 | 0.000 |
Why?
|
| Purkinje Cells | 1 | 1975 | 226 | 0.000 |
Why?
|
| Neoplasms | 1 | 1982 | 22072 | 0.000 |
Why?
|
| Blindness | 1 | 1975 | 582 | 0.000 |
Why?
|
| Carcinoma | 1 | 1982 | 2331 | 0.000 |
Why?
|
| Glucose | 1 | 1982 | 4351 | 0.000 |
Why?
|
| Motor Neurons | 1 | 1975 | 865 | 0.000 |
Why?
|
| Ultrasonography | 1 | 1983 | 5961 | 0.000 |
Why?
|
| Myocardium | 1 | 1982 | 4700 | 0.000 |
Why?
|
| Models, Biological | 1 | 1982 | 9467 | 0.000 |
Why?
|
| Melanoma | 1 | 1984 | 5697 | 0.000 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 1983 | 9276 | 0.000 |
Why?
|
| Infant | 1 | 1979 | 36060 | 0.000 |
Why?
|